Displaying 81 to 100 of 143 investments
Country Date Notes
Iomai Corp
Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants.
United States 31 Dec 2003 Series C
Kalidex Pharmaceuticals Inc
Providing next-generation anti-infective therapies to the marketplace
United States N/A
Kona Medical Inc
Developer of non-invasive treatment for hypertension
United States N/A
Kona Medical Inc
Developer of non-invasive treatment for hypertension
United States 1 May 2012 Series C
Active
Lithera Inc
United States N/A
Marinus Pharmaceuticals Inc
Development of therapeutics for treatment of CNS disorders and pain
United States Series A
Marinus Pharmaceuticals Inc
Development of therapeutics for treatment of CNS disorders and pain
United States 1 May 2009 Series B
Martek Biosciences Corp
United States N/A
Active
Meritage Pharma Inc
Developing drugs for gastrointestinal diseases
United States N/A
Microchip Biotechnologies Inc
United States 12 Nov 2009 Series B
Miramar Labs Inc
Developing devices for aesthetic indications
United States N/A
Molecular Dynamics Inc
N/A
Molecular Staging Inc
Novel technologies company for immunodiagnostics.
United States N/A
Neuralieve Inc
United States N/A
Neurogen Corp
United States N/A
Active
Neuron Systems Inc
Developing novel therapeutics for the treatment of eye diseases
United States N/A
NeuroPace Inc
United States N/A
Northstar Neuroscience Inc
A medical device company that has developed innovative medical technologies for people suffering debilitating pain, stroke and other.
United States N/A
NovaCardia Inc
Cardiovascular pharmaceutical company focused on the development and commercialization of novel clinical stage drug candidates.
United States N/A
NovaDigm Therapeutics Inc
United States N/A